Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2000

View Archived Issues

AxyS subsidiary completes merger with Discovery Partners

Rebetol now available in France for HCV

Oxigene and Techniclone sign joint venture for vascular targeting therapies

GenStar acquires lentiviral vectors, AIDS vaccine

Aventis updates R&D activities --pipeline "full and delivering"

Vaccination with TAP1 gene promotes immune response to small cell lung cancer

Frequency of adverse events due to photodynamic therapy called into question

MoliChem Medicines reports successful result of phase I trial evaluating potential CF treatment

Start of phase I trial of HCT-3012 triggers milestone payment to NicOx

Neutralase studied in percutaneous coronary intervention trial

Metabolex signs second diabetes collaboration with Parke-Davis

Cyclopentenone-based antitumor agents synthesized in China

Agents for T. cruzi infection in development at Shenyang Pharmaceutical U.

Immtech to establish research consortium for leishmaniasis therapy

Company Profile: Enanta

Bayer introduces new allergic rhinitis Rx today in Japan

Vaccines for protecting against H. pylori infection disclosed by Chiron Behring

Combination therapies for allergic conditions under study at Schering-Plough

Safe and effective bronchodilators presented by Nippon Zoki

Preparation and use of pyridazines for asthma and related disorders

4,5-Dihydroisoxazole derivatives and their use as immunomodulators and antiproliferative agents

New PCOs claimed by Novartis for airways diseases, cardiovascular disorders, urinary incontinence

Novel antibacterial agents from Scriptgen selectively inhibit bacterial RNA polymerase

Pierre Fabre's new 5-HT1A receptor agonists described in recent patent

Growth hormone secretagogues in early development at Pfizer

Structure and biological activity of new glycine-site NMDA receptor antagonist RPR-118723

DDW highlights: prucalopride as an effective and well-tolerated treatment for constipation

SuperGen acquires rights to lucanthone for treatment of brain tumors

New PYY analogue with picomolar affinity for Y4 receptors presented at DDW

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....